0001552622-14-000001.txt : 20141219 0001552622-14-000001.hdr.sgml : 20141219 20141218204013 ACCESSION NUMBER: 0001552622-14-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141219 DATE AS OF CHANGE: 20141218 EFFECTIVENESS DATE: 20141219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InCarda Therapeutics, Inc. CENTRAL INDEX KEY: 0001552622 IRS NUMBER: 264521716 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-202665 FILM NUMBER: 141297501 BUSINESS ADDRESS: STREET 1: 150 POST STREET STREET 2: SUITE 650 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 BUSINESS PHONE: 650-798-5000 MAIL ADDRESS: STREET 1: 150 POST STREET STREET 2: SUITE 650 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 D/A 1 primary_doc.xml X0707 D/A LIVE 0001552622 InCarda Therapeutics, Inc. 150 POST STREET SUITE 650 SAN FRANCISCO CA CALIFORNIA 94108 650-798-5000 DELAWARE Pleiades Cardio-Therapeutics, Inc. None Corporation true Rangachari Narasimhan 150 Post Street Suite 650 San Francisco CA CALIFORNIA 94108 Executive Officer Director Carlos A. Schuler 150 Post Street Suite 650 San Francisco CA CALIFORNIA 94108 Executive Officer Director John S. Patton 150 Post Street Suite 650 San Francisco CA CALIFORNIA 94108 Executive Officer Director Grace Colon 150 Post Street Suite 650 San Francisco CA CALIFORNIA 94108 Executive Officer Director Pharmaceuticals Decline to Disclose 06b true 0001552622-13-000002 2013-09-03 true true false 0 12900000 566977 12333023 false 13 0 0 0 Proceeds to be used as working capital, including payment of director, officer and employee salaries. false InCarda Therapeutics, Inc. /s/Grace Colon Grace Colon CEO and President 2014-12-17